Talk of a "Default" Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already Started.

A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.

Detalles Bibliográficos
Publicado en:P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management Vol. 43; no. 2; pp. 89 - 111
Autor principal: Barlas, Stephen
Formato: Journal Article
Publicado: MediMedia Managed Markets, an ICON Company Feb2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127517839&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 127517839
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10521372
        25J5
      jtl: P&T: A Peer-Reviewed Journal for Managed Care & Formulary Management
      issn: 10521372
      maglogo: N
    pubinfo:
      dt: Feb2018
      vid: 43
      iid: 2
      pid: 29351
      pub: MediMedia Managed Markets, an ICON Company
      place: Yardley, Pennsylvania
    artinfo:
      ui:
        127517839
        127517839
        NLM29386865
        NLM29386865
        127517839
      ppf: 89
      ppct: 22
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Talk of a "Default" Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already Started.
      aug:
        au: Barlas, Stephen
      sug:
        subj:
          Prescriptions, Drug
          United States Centers for Medicare and Medicaid Services
          Technology, Pharmaceutical
          Health Insurance Exchanges
          Insurance Benefits
          Benchmarking
          Drugs Economics
          Consumers
          Medication Reconciliation
      ab: A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N